Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence

European Journal of Neurology,Volume 0, Issue ja, -Not available-.

Source: European Journal of Neurology - August 22, 2018 Category: Neurology Authors: Nils Erik Gilhus , Yu Hong Source Type: research